|
Rosino Sanchez A, Garcia Torralba E, Girela Baena E, Macias Cerrolaza JA, Tudela Pallares J, Zafra Poves M, Barcelo Bayonas I, Munoz Guillermo V, Fernandez Aparicio T. Early diagnosis of prostate cancer in healthy men with germline mutations in DNA Damage Response (DDR) pathways: A literature review and proposal for a screening strategy. Actas Urol Esp (Engl Ed). 2025 Apr;49(3):501686. doi: 10.1016/j.acuroe.2025.501686. Epub 2025 Feb 11. English, Spanish. PubMed PMID: 39947293.
AÑO: 2025
|
39947293
|
Muniz-Castrillo M, Blaya Boluda N, Garcia-Torralba E, Jimenez-Fonseca P, Gonzalez Del Rey C, Balbin M, Luengo-Gil G, Ayala de la Pena F, Esteban Gonzalez E, Carmona-Bayonas A. Dysfunctional mismatch repair in patients with early triple-negative breast cancer. Clin Transl Oncol. 2025 May 4. doi: 10.1007/s12094-025-03933-x. Online ahead of print. PubMed PMID: 40319412.
AÑO: 2025; IF: 2.8
|
|
Arrizabalaga L, Garcia-Torralba E, Galluzzi L, Buque A. Targeting CDK2 to circumvent treatment resistance in HR+ breast cancer. Trends Mol Med. 2024 Dec 27:S1471-4914(24)00342-3. doi: 10.1016/j.molmed.2024.12.009. Online ahead of print. PubMed PMID: 39732571.
AÑO: 2024; IF: 12.8
|
|
Navarro Santana B, Garcia-Torralba E, Viveros-Carreno D, Rodriguez J, Pareja R, Martin A, Forte S, Krause KJ, Gonzalez-Martin JM, Ramirez PT. Complications of HIPEC for ovarian cancer surgery: evaluation over two time periods. Int J Gynecol Cancer. 2024 Jan 5;34(1):1-9. doi: 10.1136/ijgc-2023-004658. PubMed PMID: 37669829.
AÑO: 2024; IF: 4.1
|
|
Garcia-Torralba E, Perez Ramos M, Ivars Rubio A, Navarro Manzano E, Blaya Boluda N, Lloret Gil M, Aller A, de la Morena Barrio P, Garcia Garre E, Martinez Diaz F, Garcia Molina F, Chaves Benito A, Garcia-Martinez E, Ayala de la Pena F. Deconstructing neutrophil to lymphocyte ratio (NLR) in early breast cancer: lack of prognostic utility and biological correlates across tumor subtypes. Breast Cancer Res Treat. 2024 Jun;205(3):475-485. doi: 10.1007/s10549-024-07286-x. Epub 2024 Mar 7. PubMed PMID: 38453782; PubMed Central PMCID: PMC11101577.
AÑO: 2024; IF: 3.0
|